Regeneron Pharmaceuticals, Inc (REGN) said Thursday it started the first human clinical trial of REGN-COV2, its investigational dual antibody cocktail for the prevention …
French drugmaker Sanofi (SNYNF) said it is exploring additional growth opportunities for its Dupixent drug, which it is developing together with Regeneron Pharmaceuticals, …
Regeneron Pharmaceuticals, Inc (REGN) and Intellia Therapeutics, Inc. (NTLA) announced an expansion of their partnership to jointly develop potential products for the treatment of hemophilia …
Drug companies Regeneron Pharmaceuticals, Inc (REGN) and Sanofi announced that the U.S.
Regeneron Pharma (REGN) has now announced the pricing of the underwritten public secondary offering of 11,831,496 shares of its common stock held by …
Drug companies Regeneron Pharmaceuticals, Inc (REGN) and Sanofi announced that results for their Dupixent drug used for the treatment of patients with swallowing …
U.S.
With the number of confirmed COVID-19 cases rising despite worldwide lockdowns and social distancing efforts, the biotech industry is taking action. In just two months since …
A saying on Wall Street is that the market hates uncertainty, and unfortunately that looks to be playing out in global stock markets …
When investment bank Oppenheimer talks, investors listen — or they should. One of the 10 top performing research firms tracked by TipRanks, 61% …
